Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Feb 25 | SGMO | Sangamo Therapeutics, INC | FTAX | 33,637 | $0.47 | $15.8K | -1.7% | Open the original filing on SEC.gov |
| Feb 24 | SGMO | Sangamo Therapeutics, INC | FTAX | 5,291 | $0.4725 | $2.5K | -0.3% | Open the original filing on SEC.gov |
| Jan 22 | SGMO | Sangamo Therapeutics, INC | FTAX | 102,950 | $0.3985 | $41K | -5.0% | Open the original filing on SEC.gov |
| Nov 24, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 7,488 | $0.4166 | $3.1K | -0.4% | Open the original filing on SEC.gov |
| Oct 22, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 126,950 | $0.66 | $83.8K | -5.8% | Open the original filing on SEC.gov |
| Aug 24, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 7,488 | $0.5863 | $4.4K | -0.3% | Open the original filing on SEC.gov |
| Jul 22, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 126,950 | $0.4798 | $60.9K | -5.5% | Open the original filing on SEC.gov |
| May 24, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 7,488 | $0.4733 | $3.5K | -0.3% | Open the original filing on SEC.gov |
| Apr 22, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 126,950 | $0.7763 | $98.6K | -5.2% | Open the original filing on SEC.gov |